What is the current valuation of the sleep apnea-devices market in India?

The market valuation was $332.0 Million in 2024. Read More

What is the projected market size for sleep apnea-devices in India by 2035?

The market is projected to reach $707.5 Million by 2035. Read More

What is the expected CAGR for the sleep apnea-devices market in India from 2025 to 2035?

The expected CAGR during the forecast period is 7.12%. Read More

Which device type holds the largest market share in the sleep apnea-devices market?

CPAP devices had a valuation range of $150.0 Million to $320.0 Million. Read More

What are the key end-use segments for sleep apnea-devices in India?

Key end-use segments include Homecare Settings, Hospitals, and Sleep Clinics. Read More

How do online and offline distribution channels compare in the sleep apnea-devices market?

Offline distribution had a valuation range of $199.2 Million to $426.0 Million, while online distribution ranged from $66.4 Million to $146.0 Million. Read More

What is the market potential for sleep apnea-devices among different patient types?

Adults represented a market range of $200.0 Million to $450.0 Million, indicating substantial potential. Read More

Who are the leading players in the sleep apnea-devices market in India?

Key players include ResMed, Philips, Fisher & Paykel Healthcare, and Medtronic. Read More

What is the valuation range for BiPAP devices in the Indian market?

BiPAP devices had a valuation range of $80.0 Million to $150.0 Million. Read More

What is the expected growth trend for oral appliances in the sleep apnea-devices market?

Oral appliances are projected to grow with a valuation range of $30.0 Million to $70.0 Million. Read More

India Sleep Apnea Devices Market

ID: MRFR/HC/43479-HCR

200 Pages

Satyendra Maurya

Last Updated: April 06, 2026

India Sleep Apnea Devices Market Research Report By Type (diagnostic devices, therapeutic devices) and By End User (home care settings, sleep laboratories hospitals) -Forecast to 2035

India Sleep Apnea Devices Market Infographic

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Chemicals and Materials, BY Device Type (USD Million)
  1. 4.1.1 CPAP
  2. 4.1.2 BiPAP
  3. 4.1.3 APAP
  4. 4.1.4 Oral Appliances
  5. 4.1.5 Adaptive Servo-Ventilation
2. 4.2 Chemicals and Materials, BY End Use (USD Million)
  1. 4.2.1 Hospitals
  2. 4.2.2 Homecare Settings
  3. 4.2.3 Sleep Clinics
  4. 4.2.4 Ambulatory Surgical Centers
3. 4.3 Chemicals and Materials, BY Patient Type (USD Million)
  1. 4.3.1 Adults
  2. 4.3.2 Children
  3. 4.3.3 Elderly
4. 4.4 Chemicals and Materials, BY Distribution Channel (USD Million)
  1. 4.4.1 Online
  2. 4.4.2 Offline
  3. 4.4.3 Direct Sales
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Chemicals and Materials
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 ResMed (AU)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Philips (NL)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Fisher & Paykel Healthcare (NZ)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Medtronic (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 SomnoMed (AU)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Apex Medical (TW)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Breas Medical (SE)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Natus Medical (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 INDIA MARKET ANALYSIS BY DEVICE TYPE
3. 6.3 INDIA MARKET ANALYSIS BY END USE
4. 6.4 INDIA MARKET ANALYSIS BY PATIENT TYPE
5. 6.5 INDIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
6. 6.6 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF CHEMICALS AND MATERIALS
9. 6.9 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
10. 6.10 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
11. 6.11 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
12. 6.12 CHEMICALS AND MATERIALS, BY DEVICE TYPE, 2024 (% SHARE)
13. 6.13 CHEMICALS AND MATERIALS, BY DEVICE TYPE, 2024 TO 2035 (USD Million)
14. 6.14 CHEMICALS AND MATERIALS, BY END USE, 2024 (% SHARE)
15. 6.15 CHEMICALS AND MATERIALS, BY END USE, 2024 TO 2035 (USD Million)
16. 6.16 CHEMICALS AND MATERIALS, BY PATIENT TYPE, 2024 (% SHARE)
17. 6.17 CHEMICALS AND MATERIALS, BY PATIENT TYPE, 2024 TO 2035 (USD Million)
18. 6.18 CHEMICALS AND MATERIALS, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
19. 6.19 CHEMICALS AND MATERIALS, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY DEVICE TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY END USE, 2025-2035 (USD Million)
  3. 7.2.3 BY PATIENT TYPE, 2025-2035 (USD Million)
  4. 7.2.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

India Chemicals and Materials Market Segmentation

Chemicals and Materials By Device Type (USD Million, 2025-2035)

CPAP
BiPAP
APAP
Oral Appliances
Adaptive Servo-Ventilation

Chemicals and Materials By End Use (USD Million, 2025-2035)

Hospitals
Homecare Settings
Sleep Clinics
Ambulatory Surgical Centers

Chemicals and Materials By Patient Type (USD Million, 2025-2035)

Adults
Children
Elderly

Chemicals and Materials By Distribution Channel (USD Million, 2025-2035)

Online
Offline
Direct Sales

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓